Prothena Corp PLC
Seattle Genetics’ Valuation: How Does It Compare?
We believe that the enterprise-value-to-revenue multiple is the best measure for valuing Seattle Genetics (SGEN) and similar companies.
Company & Industry Overviews
How Are IBB’s American Depositary Receipts Performing?
The ADRs of the iShares Nasdaq Biotechnology ETF (IBB) had negative returns of 1% for the week ended December 4, 2015. IBB provides good exposure to international biotech stocks.